InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: None

Friday, 12/01/2017 9:29:02 AM

Friday, December 01, 2017 9:29:02 AM

Post# of 16885
They seemed to focus on the REMS with Sublocade, and Braeburn didn't really address the REMS with their NDA.

http://www.mdmag.com/medical-news/injectable-buprenorphine-sublocade-gets-fda-nod-black-box-warning-for-opioid-use-disorder
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News